Induction of immune responses by DNA vaccines in large animals

被引:134
作者
Babiuk, LA [1 ]
Pontarollo, R [1 ]
Babiuk, S [1 ]
Loehr, B [1 ]
Little-van den Hurk, SV [1 ]
机构
[1] Vet Infect Dis Org, Saskatoon, SK S7N 5E3, Canada
关键词
DNA vaccines; delivery; mucosal immunity; formulation;
D O I
10.1016/S0264-410X(02)00574-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
It is generally recognized that DNA vaccines are often less effective in large animals than in mice. One possible reason for this reduced effectiveness may be transfection deficiency and the low level of expression elicited by plasmid vectors in large animals. In our attempt to enhance transfection efficiency and, thereby, enhance immune responses, we employed a variety of methods inducing gene gun delivery or suppositories as delivery vehicles to mucosal surfaces, as well as electroporation for systemic immunization. To test these different systems, we used two different antigens-a membrane antigen from bovine herpesvirus glycoprotein (BHV-1) gD and a particulate antigen from hepatitis virus B. Gene gun and suppository delivery of BHV-1 gD to the vagina resulted in the induction of mucosal immunity not only in the vagina, but also at other mucosal surfaces. These data support the contention of a common mucosal immune system. In the case of electroporation, we were able to develop significant enhancement of gene expression following electroporation with surface electrodes (non-invasive electroporation) as well as invasive electroporation using single or six-needle electrodes. Various delivery systems such as bioject or needle delivery also influenced the immune response in both the presence and absence of electroporation. These studies also demonstrated that co-administration of plasmids coding for two different antigens (BHV-1 gD and hepatitis B surface antigen (HbsAg)) did not result in significant interference between the plasmids. These studies suggest that various combinations of delivery systems can enhance immunity to DNA-based vaccines and make them practical for administration of these vaccines in large animals. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:649 / 658
页数:10
相关论文
共 93 条
[81]  
Uchijima M, 1998, J IMMUNOL, V161, P5594
[82]   HETEROLOGOUS PROTECTION AGAINST INFLUENZA BY INJECTION OF DNA ENCODING A VIRAL PROTEIN [J].
ULMER, JB ;
DONNELLY, JJ ;
PARKER, SE ;
RHODES, GH ;
FELGNER, PL ;
DWARKI, VJ ;
GROMKOWSKI, SH ;
DECK, RR ;
DEWITT, CM ;
FRIEDMAN, A ;
HAWE, LA ;
LEANDER, KR ;
MARTINEZ, D ;
PERRY, HC ;
SHIVER, JW ;
MONTGOMERY, DL ;
LIU, MA .
SCIENCE, 1993, 259 (5102) :1745-1749
[83]   Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA [J].
Ulmer, JB ;
Fu, TM ;
Deck, RR ;
Friedman, A ;
Guan, LM ;
DeWitt, C ;
Liu, X ;
Wang, S ;
Liu, MA ;
Donnelly, JJ ;
Caulfield, MJ .
JOURNAL OF VIROLOGY, 1998, 72 (07) :5648-5653
[84]  
Van Donkersgoed J, 1999, CAN VET J, V40, P245
[85]   Gene gun DNA vaccination with Rev-independent synthetic HIV-1 gp160 envelope gene using mammalian codons [J].
Vinner, L ;
Nielsen, HV ;
Bryder, K ;
Corbet, S ;
Nielsen, C ;
Fomsgaard, A .
VACCINE, 1999, 17 (17) :2166-2175
[86]   NUCLEIC-ACIDS - VACCINES OF THE FUTURE [J].
WAINE, GJ ;
MCMANUS, DP .
PARASITOLOGY TODAY, 1995, 11 (03) :113-116
[87]   Reduction of antigen expression from DNA vaccines by coadministered oligodeoxynucleotides [J].
Weeratna, R ;
Millan, CLB ;
Krieg, AM ;
Davis, HL .
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1998, 8 (04) :351-356
[88]   Designing gene therapy vectors: avoiding immune responses by using tissue-specific promoters [J].
Weeratna, RD ;
Wu, T ;
Efler, SM ;
Zhang, L ;
Davis, HL .
GENE THERAPY, 2001, 8 (24) :1872-1878
[89]  
Whalen RG, 2001, CURR OPIN MOL THER, V3, P31
[90]   NUCLEUS-SPECIFIC AND TEMPORALLY RESTRICTED LOCALIZATION OF PROTEINS IN TETRAHYMENA MACRONUCLEI AND MICRONUCLEI [J].
WHITE, EM ;
ALLIS, CD ;
GOLDFARB, DS ;
SRIVASTVA, A ;
WEIR, JW ;
GOROVSKY, MA .
JOURNAL OF CELL BIOLOGY, 1989, 109 (05) :1983-1992